Company profile: Eagle Genomics
1.1 - Company Overview
Company description
- Provider of enterprise software enabling management, orchestration and exploitation of genomics and other life sciences data. Solutions include e[datascientist] for multi-omics data and metadata; Network Life Sciences Platform leveraging network science, AI and hypergraphs; Valuation and Decision Engine for prioritizing entity relationships; cloud-based Analysis Hub; Catalog with governance; and a Multi-layer Hypergraph tool.
Products and services
- Network Life Sciences Platform: Hypergraph-based platform leveraging network science and AI to centralize life sciences data, unifying datasets for innovation and discovery
- E[datascientist]: Multi-omics platform that manages, analyzes, and shares multi-omics data and metadata, enabling scientists to exploit data, discover biological connections, and generate knowledge
- Valuation and Decision Engine: Algorithmic framework that measures the usefulness and relevance of data and knowledge assets, prioritizing entity relationships to guide decision-making
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Eagle Genomics
QuantRx Biomedical
HQ: United States
Website
- Description: Provider of diagnostic products for the healthcare industry, focusing on their development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantRx Biomedical company profile →
Gentris
HQ: United States
Website
- Description: Provider of global pharmacogenomic testing and biorepository services, helping pharmaceutical companies and clinical research organizations integrate pharmacogenomics into drug development to deliver safer, more effective compounds to market more quickly.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentris company profile →
Inari
HQ: United States
Website
- Description: Provider of seed design and biotechnology focused on developing seeds for a nature-positive food system, leveraging predictive design and multiplex gene editing to transform agriculture and its impact on society and the environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inari company profile →
NorthGene
HQ: United Kingdom
Website
- Description: Provider of medical testing, health care and other services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthGene company profile →
QuantuMDx
HQ: United Kingdom
Website
- Description: Provider of handheld and portable low-cost diagnostic and genomic sequencing platforms, including the Q-POC rapid multiplex PCR point-of-care system; assays for SARS-CoV-2, Flu A/B, RSV; a research-use TB host immune response assay; a saliva-based SARS-CoV-2 RT-PCR test; CAPTURE-XT lab-on-chip pathogen concentration; and microarray technologies for high-throughput genetic marker screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantuMDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Eagle Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Eagle Genomics
2.2 - Growth funds investing in similar companies to Eagle Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Eagle Genomics
4.2 - Public trading comparable groups for Eagle Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →